Center for Scientific Review; Notice of Closed Meetings, 39574-39575 [2020-14165]

Download as PDF 39574 Federal Register / Vol. 85, No. 127 / Wednesday, July 1, 2020 / Notices NINDS/NIH, NSC, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892, (301) 435–6033 rajarams@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; R34 VCID Review. Date: July 14, 2020. Time: 2:15 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: Neuroscience Center, 6001 Executive Blvd., North Bethesda, MD 20852 (Video Assisted Meeting). Contact Person: Mir Ahamed Hossain, Ph.D., Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892– 9529, (301) 496–9223, mirahamed.hossain@ nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: June 25, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–14162 Filed 6–30–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; RFA–AA–20–008— VerDate Sep<11>2014 01:53 Jul 01, 2020 Jkt 250001 Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD). Date: August 3, 2020. Time: 10:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism 6700, B Rockledge Drive Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Philippe Marmillot, Ph.D., Extramural Project Review Branch, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 6700 B Rockledge Drive, Room 2118 Bethesda, MD 20892 301–443–2861 marmillotp@ mail.nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; NIAAA Review Subcommittee Member Conflict Review Panel. Date: August 4, 2020. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700 B Rockledge Drive Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Philippe Marmillot, Ph.D., Extramural Project Review Branch, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 6700 B Rockledge Drive, Room 2118 Bethesda, MD 20892 301–443–2861 marmillotp@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards, National Institutes of Health, HHS) Dated: June 25, 2020. Melanie J. Pantoja, Program Analyst,Office of Federal Advisory Committee Policy. [FR Doc. 2020–14167 Filed 6–30–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR17–158: Secondary Data Analyses to Explore NIMH Research Domain Criteria. Date: July 23, 2020. Time: 2:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health 6701 Rockledge Dr. Bethesda, MD 21740 (Virtual Meeting). Contact Person: Julius Cinque, MS Scientific Review Officer Center for Scientific Review National Institutes of Health 6701 Rockledge Drive, Room 5186, MSC 7846, Bethesda, MD 20892, cinquej@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Disease Prevention and Management, Risk Reduction and Health Behavior Change. Date: July 27, 2020. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michael J McQuestion, Ph.D., Scientific Review Officer, Center for Scientific Review National Institutes of Health, 6701 Rockledge Drive, Room 3114 MSC 7808 Bethesda, MD 20892 (301) 480–1276 mike.mcquestion@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cognition, Perception, and Language. Date: July 27, 2020. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Brian H Scott, Ph.D., Scientific Review Officer National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive Room 3142, MSC 7850, Bethesda, MD 20892, (301) 827–7490 brianscott@ mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Drug Discovery Involving the Nervous System. E:\FR\FM\01JYN1.SGM 01JYN1 Federal Register / Vol. 85, No. 127 / Wednesday, July 1, 2020 / Notices Date: July 28–29, 2020. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Aurea D De Sousa, Ph.D., Scientific Review Officer National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Room 5186, MSC 7840 Bethesda, MD 20892 301–827–6829 aurea.desousa@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Immunology. Date: July 28, 2020. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Alok Mulky, Ph.D., Scientific Review Officer, Center for Scientific Review National Institutes of Health, 6701 Rockledge Drive, Room 4203, MSC 7814 Bethesda, MD 20892 (301) 435–3566 alok.mulky@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Molecular, Cellular and Behavior Neuroscience. Date: July 28, 2020. Time: 10:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joseph G Rudolph, Ph.D., BS Chief and Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5186, MSC 7844, Bethesda, MD 20892 (301) 408– 9098 josephru@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Endocrinology, Metabolism and Reproductive Biology. Date: July 28, 2020. Time: 1:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Gregory S Shelness, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6156, MSC 7892 Bethesda, MD 20892– 7892 (301) 435–0492 shelnessgs@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis VerDate Sep<11>2014 01:53 Jul 01, 2020 Jkt 250001 Panel; RFA Panel: Tobacco Regulatory Science B. Date: July 28, 2020. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kristen Prentice, Ph.D., Scientific Review Officer, Center for Scientific Review National Institutes of Health 6701 Rockledge Drive, Room 3112, MSC 7808 Bethesda, MD 20892 301–496–0726 prenticekj@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cardiovascular Pathobiology. Date: July 29–30, 2020. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer Center for Scientific Review, National Institutes of Health 6701 Rockledge Drive, Room 4118, MSC 7814 Bethesda, MD 20892 301–408–9497 zouai@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 25, 2020. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–14165 Filed 6–30–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0033] Agency Information Collection Activities: Bonded Warehouse Proprietor’s Submission U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 60-Day notice and request for comments; extension of an existing collection of information. AGENCY: The Department of Homeland Security, U.S. Customs and Border Protection will be submitting the following information collection request to the Office of Management and Budget SUMMARY: PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 39575 (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). The information collection is published in the Federal Register to obtain comments from the public and affected agencies. Comments are encouraged and must be submitted (no later than August 31, 2020) to be assured of consideration. ADDRESSES: Written comments and/or suggestions regarding the item(s) contained in this notice must include the OMB Control Number 1651–0033 in the subject line and the agency name. To avoid duplicate submissions, please use only one of the following methods to submit comments: (1) Email. Submit comments to: CBP_ PRA@cbp.dhs.gov. (2) Mail. Submit written comments to CBP Paperwork Reduction Act Officer, U.S. Customs and Border Protection, Office of Trade, Regulations and Rulings, Economic Impact Analysis Branch, 90 K Street NE, 10th Floor, Washington, DC 20229–1177. FOR FURTHER INFORMATION CONTACT: Requests for additional PRA information should be directed to Seth Renkema, Chief, Economic Impact Analysis Branch, U.S. Customs and Border Protection, Office of Trade, Regulations and Rulings, 90 K Street NE, 10th Floor, Washington, DC 20229–1177, Telephone number 202–325–0056 or via email CBP_PRA@cbp.dhs.gov. Please note that the contact information provided here is solely for questions regarding this notice. Individuals seeking information about other CBP programs should contact the CBP National Customer Service Center at 877–227–5511, (TTY) 1–800–877–8339, or CBP website at https://www.cbp. gov/. SUPPLEMENTARY INFORMATION: CBP invites the general public and other Federal agencies to comment on the proposed and/or continuing information collections pursuant to the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). This process is conducted in accordance with 5 CFR 1320.8. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) suggestions to enhance the quality, utility, and clarity of the information to E:\FR\FM\01JYN1.SGM 01JYN1

Agencies

[Federal Register Volume 85, Number 127 (Wednesday, July 1, 2020)]
[Notices]
[Pages 39574-39575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14165]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR17-158: Secondary Data Analyses to Explore NIMH Research 
Domain Criteria.
    Date: July 23, 2020.
    Time: 2:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health 6701 Rockledge Dr. Bethesda, 
MD 21740 (Virtual Meeting).
    Contact Person: Julius Cinque, MS Scientific Review Officer Center 
for Scientific Review National Institutes of Health 6701 Rockledge 
Drive, Room 5186, MSC 7846, Bethesda, MD 20892, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Disease Prevention and Management, Risk 
Reduction and Health Behavior Change.
    Date: July 27, 2020.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael J McQuestion, Ph.D., Scientific Review 
Officer, Center for Scientific Review National Institutes of Health, 
6701 Rockledge Drive, Room 3114 MSC 7808 Bethesda, MD 20892 (301) 480-
1276 [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Cognition, Perception, and Language.
    Date: July 27, 2020.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Brian H Scott, Ph.D., Scientific Review Officer 
National Institutes of Health, Center for Scientific Review, 6701 
Rockledge Drive Room 3142, MSC 7850, Bethesda, MD 20892, (301) 827-7490 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Drug Discovery Involving the Nervous System.

[[Page 39575]]

    Date: July 28-29, 2020.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Aurea D De Sousa, Ph.D., Scientific Review Officer 
National Institutes of Health, Center for Scientific Review, 6701 
Rockledge Drive, Room 5186, MSC 7840 Bethesda, MD 20892 301-827-6829 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Immunology.
    Date: July 28, 2020.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Alok Mulky, Ph.D., Scientific Review Officer, 
Center for Scientific Review National Institutes of Health, 6701 
Rockledge Drive, Room 4203, MSC 7814 Bethesda, MD 20892 (301) 435-3566 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Molecular, Cellular and Behavior Neuroscience.
    Date: July 28, 2020.
    Time: 10:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Joseph G Rudolph, Ph.D., BS Chief and Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5186, MSC 7844, Bethesda, MD 20892 
(301) 408-9098 [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Topics in Endocrinology, Metabolism and 
Reproductive Biology.
    Date: July 28, 2020.
    Time: 1:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Gregory S Shelness, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of Health, 
6701 Rockledge Drive, Room 6156, MSC 7892 Bethesda, MD 20892-7892 (301) 
435-0492 [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA Panel: Tobacco Regulatory Science B.
    Date: July 28, 2020.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kristen Prentice, Ph.D., Scientific Review Officer, 
Center for Scientific Review National Institutes of Health 6701 
Rockledge Drive, Room 3112, MSC 7808 Bethesda, MD 20892 301-496-0726 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Cardiovascular Pathobiology.
    Date: July 29-30, 2020.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 Rockledge 
Drive Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer 
Center for Scientific Review, National Institutes of Health 6701 
Rockledge Drive, Room 4118, MSC 7814 Bethesda, MD 20892 301-408-9497 
[email protected].

    (Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)


    Dated: June 25, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-14165 Filed 6-30-20; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.